SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-038593
Filing Date
2023-05-11
Accepted
2023-05-11 17:01:36
Documents
47
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_oramedphar.htm   iXBRL 10-Q 448870
2 CERTIFICATION f10q0323ex31-1_oramedphar.htm EX-31.1 10122
3 CERTIFICATION f10q0323ex31-2_oramedphar.htm EX-31.2 10235
4 CERTIFICATION f10q0323ex32-1_oramedphar.htm EX-32.1 3517
5 CERTIFICATION f10q0323ex32-2_oramedphar.htm EX-32.2 3534
  Complete submission text file 0001213900-23-038593.txt   2735802

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ormp-20230331.xsd EX-101.SCH 31215
7 XBRL CALCULATION FILE ormp-20230331_cal.xml EX-101.CAL 33785
8 XBRL DEFINITION FILE ormp-20230331_def.xml EX-101.DEF 132061
9 XBRL LABEL FILE ormp-20230331_lab.xml EX-101.LAB 276348
10 XBRL PRESENTATION FILE ormp-20230331_pre.xml EX-101.PRE 139301
41 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_oramedphar_htm.xml XML 243120
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 23912027
SIC: 2834 Pharmaceutical Preparations